CAPITAL ORIENT’s Oncology & HemOnc Conference featured insightful panel discussions and one-on-ones with leading companies and key opinion leaders in the space. The panels, moderated by the CAPITAL ORIENT Healthcare Team, provided perspectives and insights on a variety of topics, including:

• Cell Therapy & Transplant
• Immuno-Oncology
• Leukemia and MDS
• Drug Development & Manufacturing
• Multiple Myeloma & Lymphoma